We may earn a commission if you buy through this link, at no extra cost to you.
Why people look each one up, what the record actually shows, who it was shown in, and how much to trust it. One card per compound in the vendor's catalog. No favorites, no "best for."
Evidence climbs five rungs. A result in a dish is rung 1. Rats and mice are rung 2. A handful of people is rung 3. A large trial with a placebo group is rung 4. An approved medicine is rung 5.
Each card below tells you the highest rung a compound has reached and where it stopped. Most research peptides stop at rung 2. The ones that reached rung 3 did so in small studies that measured a blood marker or a lab value, not a health outcome.
Three lights, same as the rest of the site: human controlled trials on file · animal, cell, or tiny human studies only · nothing on file
Alphabetical. Dates matter — regulatory status changed in April and July 2026 and we re-check quarterly.
Why people look it up. Injury recovery — tendons, muscle, gut. That reputation rests almost entirely on rat studies; no one has shown it in people.
What it is. A short piece of a protein found in stomach juice, made in a lab.
What researchers have looked at. Tendon, muscle, ligament and gut injury; also blood-vessel growth.
In whom. Almost entirely rats. No human trials on record.
Status. Not approved anywhere. FDA compounding page: “nominated but withdrawn” (Apr 2026). An FDA advisory panel voted in July 2026 to recommend it for the compounding list — advisory only, nothing has legally changed. WADA-banned (S0).
What's unknown. Human safety by any route. Whether rat results carry over to people at all.
Why people look it up. Tissue repair and flexibility. The reputation comes from animal studies of thymosin beta-4 and from sport, where it is banned — not from human trials of the vial sold as TB-500.
What it is. A protein your cells already make in large amounts. “TB-500” is the name research vendors use; the lab report for this vendor's product reads full-length thymosin beta-4.
What researchers have looked at. Wound repair, cornea, heart tissue, cell movement.
In whom. Mostly animals and cells. Thymosin beta-4 itself has been in small human trials (eye drops, wound gels) run by a drug developer — those are not the vial sold as TB-500.
Status. Not approved. FDA: “nominated but withdrawn” (Apr 2026); July 2026 panel recommended it (advisory). WADA-banned (S2.3).
What's unknown. Anything about the injectable research product in people. Whether what you receive is the fragment or the full protein — check the COA identity line.
Why people look it up. Gut inflammation. Mouse and cell studies only — FDA notes there is no human exposure data by any route.
What it is. The last three amino acids of a hormone (α-MSH) your body makes.
What researchers have looked at. Gut inflammation; how it gets into intestinal cells.
In whom. Mice and cells. No human data on record.
Status. Not approved. FDA: “nominated but withdrawn” — FDA notes it has no human exposure data by any route (Apr 2026). July 2026 panel recommended it (advisory). WADA: not named.
What's unknown. Everything in people. Which form vendors actually sell (some listings' molecular weight matches an acetylated version, not plain KPV).
Why people look it up. Skin, hair and wound appearance — the “copper peptide” in cosmetics. Cell studies and small cosmetic skin trials; nothing on injectable use in people.
What it is. A tiny piece of protein bound to a copper atom. Found in human blood; drops with age.
What researchers have looked at. Skin, wound repair, hair, gene expression; recently gut inflammation and brain aging in mice.
In whom. Cells, mice, and small cosmetic skin studies in people. Most of the literature is written by the compound's discoverer.
Status. Not approved as a drug. FDA lists it as under evaluation for compounding by non-injectable routes only (Category 1, May 2026); the injectable form is “nominated but withdrawn.” WADA: not named.
What's unknown. Injectable use in people — FDA has flagged immunogenicity risk. Whether the vial contains copper (one listing's molecular weight matches the copper-free peptide).
Why people look it up. Raising growth hormone. One small human study measured exactly that — a blood level, in the with-DAC form — and nothing downstream of it.
What it is. A modified copy of the part of growth-hormone-releasing hormone that does the signaling. “No DAC” means the long-acting attachment is left off.
What researchers have looked at. Raising growth hormone and IGF-1 in the blood.
In whom. One published human study (healthy adults, 2006) — of the with-DAC version. The no-DAC version sold here has less published data.
Status. Not approved. FDA: “nominated but withdrawn” (Apr 2026). WADA-banned (S2, growth-hormone-releasing factors).
What's unknown. Long-term effects of pushing growth hormone. Any human data on the exact no-DAC product.
Why people look it up. Growth-hormone release with a “gentler” reputation. The gentler part comes from a 1998 animal paper; the human data is one small surgical-recovery study.
What it is. A lab-made peptide that mimics ghrelin, the “hunger hormone,” at the receptor that triggers growth-hormone release.
What researchers have looked at. Growth-hormone release; gut movement after bowel surgery.
In whom. Animals first (1998). Then a small randomized human study for post-surgery gut recovery (2014) run by a drug developer; the program did not become a medicine.
Status. Not approved. FDA: Category 2 (“significant safety risk”) for outsourcing facilities, and “nominated but withdrawn” for pharmacies (Apr 2026). WADA-banned (S2).
What's unknown. Anything beyond short-term use. Why the drug program stopped.
Why people look it up. Energy and “anti-aging.” What the human studies actually show: blood NAD+ goes up after an infusion and people tolerate it. Nothing beyond that has been measured.
What it is. A molecule every living cell uses to move energy around. It is not a peptide — it's a nucleotide, chemically closer to the building blocks of DNA. Your body makes it; levels fall with age.
What researchers have looked at. Whether infusing it raises blood levels and is tolerated; oxidative-stress and inflammation markers; sleep. Separately, oral precursors (NR, NMN) have been studied for raising blood NAD+.
In whom. IV NAD+: five small human studies total as of September 2026, mostly uncontrolled, 8–14 people each. Oral precursors: several small placebo-controlled trials that measured blood levels, not health outcomes.
Status. Not an approved drug. Different from the peptides: FDA lists NAD as “under evaluation” for pharmacy compounding (503A Category 1, May 2026), which is why clinics offer it. Not on the compounding safety-risk page. WADA: not named.
What's unknown. Whether raising blood NAD+ changes anything that matters. Long-term safety. A September 2026 review calls the evidence “preliminary and insufficient to support routine clinical or wellness use.”
Why people look them up. “Recovery” combinations — the idea that the parts add up. No study of any of these combinations exists.
What they are. The single compounds above, freeze-dried together in one vial at a labeled ratio.
What researchers have looked at. Nothing. We found no published study of any of these combinations. The evidence for a blend is the evidence for its weakest component, at best.
Status. Each component carries its own status above; a blend containing BPC-157 or TB-500 is WADA-banned.
What's unknown. Whether the components interact in the vial. Whether the label ratio matches the lab report — on this vendor, one Restore blend ratio has a COA and one doesn't.
Because nobody knows. "Best for recovery" is a claim about a person, and there are no controlled human trials behind any compound on this page except a few dozen people measured for a blood marker. What we can tell you is what's on the record, who it was tested in, and whether the vial in front of you matches its paperwork. That's a background check. The rest is a guess, and we don't publish guesses.
If a page somewhere tells you a peptide "fixes" or "boosts" something in you, ask it for the rung.
Paste a product link or a lot number. We pull the lab report, look it up at the lab, and reply personally within 48 hours with the three lights. Any vendor. Research use only.
What each document proves, what it doesn't, and where to find it. Research use only.